Talis Biomedical Corp Quarterly Return On Assets in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Talis Biomedical Corp quarterly/annual Return On Assets history and growth rate from Q3 2021 to Q2 2024.
  • Talis Biomedical Corp Return On Assets for the quarter ending June 30, 2024 was -57.2 %, a 3.16% decline year-over-year.
  • Talis Biomedical Corp annual Return On Assets for 2023 was -54.2 %, a 2.29% increase from 2022.
  • Talis Biomedical Corp annual Return On Assets for 2022 was -55.4 %, a 2.48% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -57.2 -1.75 -3.16% Apr 1, 2024 Jun 30, 2024
Q1 2024 -56.2 -1.69 -3.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -54.2 +1.27 +2.29% Oct 1, 2023 Dec 31, 2023
Q3 2023 -56.7 -6.37 -12.7% Jul 1, 2023 Sep 30, 2023
Q2 2023 -55.4 -5.61 -11.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -54.5 +1.37 +2.45% Jan 1, 2023 Mar 31, 2023
Q4 2022 -55.4 +1.41 +2.48% Oct 1, 2022 Dec 31, 2022
Q3 2022 -50.3 +14.3 +22.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -49.8 Apr 1, 2022 Jun 30, 2022
Q1 2022 -55.8 Jan 1, 2022 Mar 31, 2022
Q4 2021 -56.8 Oct 1, 2021 Dec 31, 2021
Q3 2021 -64.7 Jul 1, 2021 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.